The Evolving Frontier of Repeat Transcatheter Valve-in-Valve Mitral Interventions in Small Children

Q: What is the clinical evidence from this study?

Study design: Editorial. Population: Severe congenital mitral valve disease in infants and young children. Intervention: Mitral Melody Valve (MiM) and repeat transcatheter valve-in-valve intervention vs. Conventional surgical bioprosthetic or mechanical prosthetic valves.

Ming Chern Leong; Mazeni Alwi

doi:10.1016/j.jaccas.2026.110394

September 1, 2026JACC Case ReportsOpen Access

The Evolving Frontier of Repeat Transcatheter Valve-in-Valve Mitral Interventions in Small Children

View Full Paper

Ask AI

Bookmark

Share

Key result

Transcatheter mitral Melody valve-in-valve intervention bridges children to mechanical replacement, though 17%-28% of systemic Melody valves develop structural dysfunction within 1 year.

Graphical abstract published by JACC Case Reports — Graphical abstract · Published by JACC Case Reports · CC BY-NC-ND

Key Points

To review the durability, biomechanical constraints, and clinical role of repeat transcatheter valve-in-valve mitral procedures using the Melody valve as a bridge to growth in pediatric patients.
Clinical review and commentary examining the off-label use and serial transcatheter deployment of the bovine jugular vein Melody valve in the pediatric mitral position.
Synthesized published midterm data across multiple cohort studies evaluating reintervention frequency, hemodynamic failure modes, and mortality in young children.
Accelerated structural valve deterioration or early reintervention occurs in 17% to 28% of systemic Melody valves within the first year following implantation due to high closing pressures and shear stress.
Freedom from reoperation reaches approximately 80% for the Melody valve and 83% for the Sapien 3 valve at 24 months, with 50% of patients in one cohort transitioning to mechanical mitral valve replacement by 3.5 years.
Cumulative reintervention rates reach 9% at 1 year and 39% at 3 years in infant series, with serial valve-in-valve stacking carrying risks of outflow obstruction, paravalvular gaps, and endocarditis.

Structured PICO

P

Population

Infants and young children with severe congenital mitral valve disease undergoing transcatheter or surgical mitral Melody valve replacement and repeat valve-in-valve interventions.

I

Intervention

Off-label surgical and transcatheter mitral valve replacement and repeat transcatheter valve-in-valve intervention using the stented bovine jugular vein prosthesis (Melody valve) or Sapien 3 valve

Limitations

Accelerated structural valve deterioration and calcification of bovine jugular vein tissue under systemic left ventricular pressures
Unpredictable risks of high-pressure balloon redilation including stent distortion, leaflet tearing, and acute mitral regurgitation
Increased local metal burden from layered stents compromising effective orifice area and threatening neo-left ventricular outflow tract obstruction
Compounding rigidity of stacked frames complicating eventual surgical explantation
Persistent long-term risk of late infective endocarditis associated with bovine jugular vein tissue
Accelerated structural valve deterioration, collagen fragmentation, leaflet prolapse, and dystrophic calcification due to high-velocity systolic shear stress and elevated closing pressures in the systemic left ventricle
High-pressure balloon redilation of calcified valves carries unpredictable risks of distorting stent frames, tearing leaflets, or inducing severe acute mitral regurgitation
Layered valve-in-valve procedures increase local metal burden, compromise effective orifice area, elevate baseline transvalvular gradients, and risk neo-left ventricular outflow tract obstruction
Compounding rigidity of stacked frames complicates eventual surgical explantation and definitive mechanical valve placement
Persistent long-term risks of late infective endocarditis associated with bovine jugular vein tissue

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Transcatheter mitral valve-in-valve intervention using the Melody valve serves as an effective, growth-accommodating bridge to delay redo sternotomy in small children with congenital mitral valve disease until they can accommodate a definitive mechanical prosthesis.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Leong et al. (2026) conducted an editorial in Severe congenital mitral valve disease in infants and young children. Mitral Melody Valve (MiM) and repeat transcatheter valve-in-valve intervention vs. Conventional surgical bioprosthetic or mechanical prosthetic valves was evaluated. Transcatheter mitral Melody valve-in-valve intervention bridges children to mechanical replacement, though 17%-28% of systemic Melody valves develop structural dysfunction within 1 year.

synapsesocial.com/papers/6ac1bb702ee2d5767be98ee9 https://doi.org/10.1016/j.jaccas.2026.110394

View Full Paper

Ask AI

Bookmark

Share

The Evolving Frontier of Repeat Transcatheter Valve-in-Valve Mitral Interventions in Small Children

Key Points

Structured PICO

Limitations

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

The Evolving Frontier of Repeat Transcatheter Valve-in-Valve Mitral Interventions in Small Children

Key Points

Structured PICO

Limitations

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading